Lv11
30 积分 2022-06-07 加入
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study
1小时前
已完结
Inclisiran for the Treatment of Cardiovascular Disease: the Orion Clinical Development Program
4天前
已完结
Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9
4天前
已完结
NEJM at ESC — Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
9天前
已完结
Plozasiran and Apolipoprotein C-III Inhibition: Lipoprotein Particle Insights and Cardiovascular Implications
9天前
已完结
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk—A Systematic Review and Meta Analysis
10天前
已关闭
Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study
10天前
已完结
Serum Prealbumin and Retinol-Binding Protein Concentrations in Japanese-Type Familial Amyloid Polyneuropathy
18天前
已关闭
Regulation of PDGF and its receptors in fibrotic diseases
1个月前
已完结
皖公网安备34019202002308
